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Abstract
The Gram-negative bacterial plant pathogen Xanthomonas campestris pv. vesicatoria employs a type III secretion (T3S)
system to inject bacterial effector proteins into the host cell cytoplasm. One essential pathogenicity factor is HrpB2, which is
secreted by the T3S system. We show that secretion of HrpB2 is suppressed by HpaC, which was previously identified as a
T3S control protein. Since HpaC promotes secretion of translocon and effector proteins but inhibits secretion of HrpB2,
HpaC presumably acts as a T3S substrate specificity switch protein. Protein–protein interaction studies revealed that HpaC
interacts with HrpB2 and the C-terminal domain of HrcU, a conserved inner membrane component of the T3S system.
However, no interaction was observed between HpaC and the full-length HrcU protein. Analysis of HpaC deletion
derivatives revealed that the binding site for the C-terminal domain of HrcU is essential for HpaC function. This suggests
that HpaC binding to the HrcU C terminus is key for the control of T3S. The C terminus of HrcU also provides a binding site
for HrpB2; however, no interaction was observed with other T3S substrates including pilus, translocon and effector proteins.
This is in contrast to HrcU homologs from animal pathogenic bacteria suggesting evolution of distinct mechanisms in plant
and animal pathogenic bacteria for T3S substrate recognition.
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Introduction
Many Gram-negative bacterial pathogens of plants and animals
depend on a type III secretion (T3S) system to successfully infect
their hosts [1]. The term ‘‘T3S system’’ refers to both
translocation-associated and flagellar T3S systems that evolved
from a common ancestor [2]. Eleven components of the
membrane-spanning basal body are conserved, suggesting a
similar overall architecture of the secretion apparatus [1,3]. Main
structural differences are found in the extracellular appendages
associated with the basal body. The flagellar T3S apparatus is
connected via an extracellular hook to the filament, the key
bacterial motility organelle [4]. By contrast, the basal body of
translocation-associated T3S systems is associated with an
extracellular pilus (plant pathogens) or needle (animal pathogens),
which serve as conduits for secreted proteins to the host-pathogen
interface [1,5]. Pilus and needle are proposed to be linked to the
T3S translocon, a channel-like protein complex that is inserted
into the eukaryotic plasma membrane and allows protein
translocation into the host cell cytosol [6,7].
Translocation-associated T3S systems secrete two types of
proteins, i.e., extracellular components of the secretion apparatus
such as needle/pilus and translocon proteins, and effectors that are
translocated into the host cell [3]. Efficient secretion and/or
translocation of T3S substrates depends on a signal in the N
terminus, which is not conserved on the amino acid level [1,8,9].
In many cases, specific T3S chaperones bind to one or several
homologous T3S substrates in the bacterial cytoplasm and
promote stability and/or secretion of their respective binding
partners. T3S chaperones are small, acidic and leucine-rich
proteins that presumably guide secreted proteins to the secretion
apparatus at the inner membrane [1,10,11].
Given the architecture of the T3S system, it is conceivable that
secretion of extracellular components of the secretion apparatus
precedes effector protein translocation. In translocation-associated
and flagellar T3S systems from animal pathogenic bacteria,
experimental evidence suggests that substrate specificity is altered
by so-called T3S substrate specificity switch (T3S4) proteins, e.g.,
YscP from Yersinia spp. and the flagellar homolog FliK [12–14].
The substrate specificity switch depends on the C-terminal
cytoplasmic domain of a conserved inner membrane protein of
the FlhB/YscU family [12,13]. T3S4 proteins are not highly
conserved among different pathogens and have so far only been
identified in animal pathogenic bacteria [14,15]. It therefore
remained enigmatic whether plant pathogenic bacteria employ
similar mechanisms to orchestrate secretion of different T3S
substrates.
In our laboratory, we study T3S of the plant pathogenic
bacterium Xanthomonas campestris pv. vesicatoria, the causal agent of
bacterial spot disease in pepper and tomato. The T3S system of X.
campestris pv. vesicatoria is essential for bacterial growth and disease
symptom formation in susceptible host plants and the induction of
the hypersensitive response (HR) in resistant plants. The HR is a
rapid programmed cell death at the infection site that is triggered
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avirulence (Avr) proteins, in plants that carry a cognate disease
resistance gene [16,17]. In susceptible plants, effector proteins
presumably modulate host cellular pathways to the pathogen’s
benefit and thus primarily act as virulence factors [18,19].
The T3S system from X. campestris pv. vesicatoria is encoded by
the 23-kb chromosomal hrp (hypersensitive response and pathoge-
nicity) gene cluster, which is organized in eight operons and
contains 25 genes [20–23]. Eleven genes (termed hrc for hrp
conserved) encode proteins that are conserved among plant and
animal pathogenic bacteria [24]. Most hrp genes are essential for
bacterial pathogenicity [25]. Several Hrp proteins are secreted and
thus constitute extracellular components of the T3S system such as
the pilus protein HrpE and the translocon protein HrpF [25–27].
T3S of extracellular components of the secretion apparatus and
effector proteins is presumably controlled by the products of hpa
(hrp-associated) genes that are encoded in the hrp gene cluster and
contribute to pathogenicity [28–31]. Examples are the export
control protein HpaC, which is required for the efficient secretion
of translocon and some effector proteins, and the global T3S
chaperone HpaB, which promotes secretion and translocation of
multiple effector proteins [30,31].
In this study, we analyzed HrpB2, which is an essential
pathogenicity factor of X. campestris pv. vesicatoria. HrpB2 is a 13.7-
kDa protein that is encoded by the second gene of the hrpB operon
and is secreted by the T3S system [25,32]. Homologous proteins
are present in Xanthomonas spp., Burkholderia spp. and Ralstonia
solanacearum, suggesting that HrpB2 also plays an important role in
other pathogens. In X. campestris pv. vesicatoria, HrpB2 is essential
for pilus formation and T3S and is therefore presumably one of
the first proteins that travel the T3S apparatus [25,26]. However,
the mode of HrpB2 action is unknown because HrpB2 does not
share significant sequence or structural similarity with a protein of
known function. Here, we provide experimental evidence that
secretion of HrpB2 is required for bacterial pathogenicity.
Secretion of HrpB2 is significantly enhanced in the absence of
the export control protein HpaC. Protein-protein interaction
studies showed that HrpB2 binds to HpaC and to the C-terminal
domain of the conserved inner membrane protein HrcU, which
also interacts with HpaC. Our data suggest that the interaction
between HpaC and the C-terminal domain of HrcU promotes a
switch in substrate specificity of the T3S system from HrpB2
secretion to secretion of translocon and effector proteins.
Results
HrpB2 is essential for bacterial pathogenicity and T3S
Previously, we identified HrpB2 as a T3S substrate of X.
campestris pv. vesicatoria strain 85-10 [25]. Infection studies with
hrpB2 deletion mutant strains revealed that HrpB2 is crucial for
disease symptoms in susceptible and the HR induction in resistant
pepper plants [25]. Similar results were obtained with strains 85*
and 85*DhrpB2, which carry hrpG*, a mutated version of the key
regulatory gene hrpG in the bacterial chromosome (Fig 1A). hrpG*
leads to constitutive expression of the T3S system and is key for the
analysis of in vitro T3S [33]. It is noteworthy that in planta growth of
hrpG* strains is like wild-type [34]. The hrpB2 mutant phenotype
could be complemented by ectopic expression of hrpB2, suggesting
that loss of pathogenicity was specifically due to the deletion of
hrpB2 and did not result from a polar effect of the mutation on
expression of other genes in the hrpB operon (Fig. 1A).
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Figure 1. HrpB2 is essential for pathogenicity and T3S. (A) HrpB2
is crucial for disease symptom formation and HR induction. X.
campestris pv. vesicatoria strains 85* (wt) and 85*DhrpB2 (DhrpB2)
carrying the empty vector (-) or synthesizing HrpB2 and HrpB2D10–25 as
indicated were inoculated into susceptible ECW and resistant ECW-10R
pepper plants. Dashed lines indicate the infiltrated areas. Disease
symptoms and the HR were photographed five days after infiltration. (B)
In vitro secretion of translocon and pilus proteins is abolished in the
hrpB2 deletion mutant. Strains 85* (wt) and 85*DhrpB2 (DhrpB2) were
incubated in secretion medium and total cell extracts (TE) and culture
supernatants (SN) were analyzed by immunoblotting, using antibodies
specific for HrpF, XopA and AvrBs3, respectively. HrpE1–50-AvrBs3D2
was expressed from an ectopic plasmid under control of the native hrpE
promoter.
doi:10.1371/journal.ppat.1000094.g001
Author Summary
The Gram-negative plant pathogenic bacterium Xantho-
monas campestris pv. vesicatoria is the causal agent of
bacterial spot disease in pepper and tomato. Pathogenicity
of X. campestris pv. vesicatoria depends on a type III
protein secretion (T3S) system that injects bacterial
effector proteins directly into the host cell cytosol. The
T3S system is a highly complex nanomachine that spans
both bacterial membranes and is associated with an
extracellular pilus and a translocon that inserts into the
host cell membrane. Given the architecture of the
secretion apparatus, it is conceivable that pilus formation
precedes effector protein secretion. The pilus presumably
consists of two components, i.e., the major pilus subunit
HrpE and HrpB2, which is required for pilus assembly.
Secretion of HrpB2 is suppressed by HpaC that switches
substrate specificity of the T3S system from secretion of
HrpB2 to secretion of translocon and effector proteins. The
substrate specificity switch depends on the cytoplasmic
domain of HrcU, which is a conserved inner membrane
protein of the T3S apparatus that interacts with HrpB2 and
HpaC.
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abolished in hrpB2 deletion mutants suggested that HrpB2 is
involved in T3S [25]. To investigate the contribution of HrpB2 to
secretion of additional T3S substrates, strains 85* and 85*DhrpB2
were incubated in secretion medium, and total cell extracts and
culture supernatants were analyzed by immunoblotting using
specific polyclonal antibodies. We tested secretion of the putative
translocon proteins HrpF and XopA, and the pilus protein HrpE.
For technical reasons, HrpE was studied as a fusion protein
consisting of the N-terminal 50 amino acids of HrpE and the
reporter protein AvrBs3D2, which is a derivative of AvrBs3.
AvrBs3D2 lacks the first 152 amino acids and thus the secretion
and translocation signal [35]. It was previously demonstrated that
the N-terminal 50 amino acids of HrpE restore secretion but not
translocation of AvrBs3D2, indicating that they contain a
functional T3S signal [36]. Fig. 1B shows that HrpF, XopA and
HrpE1–50-AvrBs3D2 were present in the culture supernatant of the
wild-type strain but were not detectable in the supernatant of the
hrpB2 deletion mutant, suggesting that HrpB2 is essential for
secretion of these proteins.
Secretion of HrpB2 is inhibited by HpaC
Since HrpB2 is secreted and is also required for T3S, it is
presumably one of the first substrates that travel the T3S apparatus
[25]. Notably, the amount of HrpB2 present in the culture
supernatant of strain 85* is at the detection limit of the HrpB2-
specific antibody [25]. Similar results were observed for a C-
terminally c-Myc epitope-tagged version of HrpB2, suggesting that
HrpB2 is only weakly secreted by the T3S system (Fig. 2A). To
investigate whether HrpB2 secretion is regulated by the known
export control proteins HpaB and HpaC, we performed in vitro T3S
assays with strains 85*, the hpaB deletion mutant 85*DhpaB and the
hpaC deletion mutant 85*DhpaC. We did not detect any influence of
the global T3S chaperone HpaB on secretion of HrpB2.
Interestingly, however, significantly increased amounts of HrpB2
were secreted by strain 85*DhpaC (Fig. 2). This was not due to a
general increase of T3S in strain 85*DhpaC since secretion of the
translocon protein HrpF was reduced when compared to the wild-
type strain 85* (Fig. 2A and C). This is in agreement with the
previous finding that HpaC is required for the efficient secretion of
translocon and some effector proteins [31]. Oversecretion of HrpB2
in strain 85*DhpaC was specifically due to deletion of hpaC since the
secretion phenotype was complemented by ectopic expression of
hpaC-c-myc (Fig. 2B). We did not detect HrpB2 in the culture
supernatant of the T3S double mutant 85*DhpaCDhrpE, which
additionally lacks the Hrp pilus gene hrpE (Fig. 2C). We therefore
conclude that increased HrpB2 secretion in strain 85*DhpaC was
mediated by the translocation-associated T3S system.
The N terminus of HrpB2 is crucial for protein function
Next, we investigated whether secretion of HrpB2 is crucial for
protein function. For this, we analyzed N-terminal HrpB2 deletion
derivatives. Surprisingly, deletion of the N-terminal 10 amino
acids of HrpB2 did not abolish its secretion in wild-type and hpaC
deletion mutant strains (data not shown). By contrast, secretion of
a HrpB2 deletion derivative lacking amino acids 10 to 25 was
severely reduced in strain 85*DhpaC, suggesting that amino acids
10 to 25 harbour at least part of the secretion signal (Fig. 2D).
Notably, HrpB2D10–25 did not complement the hrpB2 mutant
phenotype with respect to disease symptom formation in
susceptible and HR induction in resistant pepper plants (Fig. 1A).
This was not due to the presence of the C-terminal c-Myc epitope
since complementation studies were performed with untagged
HrpB2 and derivatives. Immunoblot analysis of bacterial total cell
extracts revealed that HrpB2D10–25 was stably synthesized in strain
85*DhrpB2 (Fig. 2D). We therefore conclude that amino acids 10
to 25 are crucial for efficient secretion of HrpB2 and that HrpB2
secretion is presumably required for protein function.
HrpB2 interacts with HpaC
To investigate whether oversecretion of HrpB2 in the hpaC
deletion mutant was due to increased hrpB2 transcript levels, we
performed reverse transcriptase (RT)-PCR analysis of strains 85*
and 85*DhpaC grown under secretion-permissive conditions.
Fig. 3A shows that hrpB2 transcript levels were comparable in
both strains, suggesting that deletion of hpaC did not affect the
transcriptional regulation of hrpB2.
We therefore studied whether there is an interaction between
HrpB2 and HpaC proteins using glutathione S-transferase (GST)
pull-down assays. For this, GST and a GST-HpaC fusion protein
were synthesized in Escherichia coli, immobilized on glutathione
sepharose matrix and incubated with an E. coli lysate containing
HrpB2-c-Myc. Bound proteins were eluted from the matrix and
analyzed by immunoblotting using c-Myc epitope- and GST-
specific antibodies. HrpB2-c-Myc specifically eluted with GST-
HpaC but not with GST alone, indicating that HrpB2 interacts
with HpaC (Fig. 3B). Similar results were obtained with an N-
terminal HrpB2 deletion derivative that lacks the first 26 amino
acids and thus at least part of the T3S signal (Fig. 3B; see above).
The interaction between HpaC and HrpB2 is reminiscent of our
previous finding that HpaC binds to different T3S substrates
including translocon and effector proteins [31]. We did not
observe an interaction between HrpB2 and the global T3S
chaperone HpaB (Fig. 3C), which is in line with the fact that HpaB
does not control HrpB2 secretion (see above).
HrpB2 binds to the C-terminal domain of HrcU that is
proteolytically cleaved
In animal pathogenic bacteria T3S substrate recognition is
mediated by members of the conserved FlhB/YscU family of inner
membrane proteins [37–39]. YscU, FlhB and their homologs
contain four predicted transmembrane domains and a C-terminal
cytoplasmic protein region that is cleaved between the asparagine
and proline residues of the conserved NPTH motif [39–43]. To
investigate a possible cleavage of the YscU/FlhB homolog HrcU
from X. campestris pv. vesicatoria, we synthesized a C-terminally c-
Myc epitope-tagged HrcU derivative in both E. coli and X.
campestris pv. vesicatoria and analyzed protein extracts by immuno-
blotting using a c-Myc-specific antibody. We detected two proteins
of approximately 50 kDa and 20 kDa in E. coli and X. campestris pv.
vesicatoria extracts irrespective of the growth medium (Fig. 4A).
Both proteins presumably correspond to full-length HrcU
(39 kDa+5 kDa epitope tag) and the predicted C-terminal
cleavage product (10 kDa+5 kDa epitope tag). The HrcU proteins
migrate slower than predicted, which was previously also reported
for other T3S system-associated proteins from X. campestris pv.
vesicatoria [27,29].
Because yeast two-hybrid-based interaction studies of proteins
from Xanthomonas axonopodis pv. citri suggested an interaction
between HrpB2 and the C-terminal domain of HrcU [44], we
performed GST pull-down assays with HrpB2 and HrcU from X.
campestris pv. vesicatoria. For this, we generated expression
constructs encoding GST-HrcU, GST-HrcU-c-Myc and GST-
HrcU255–357, the latter of corresponds to the C-terminal
cytoplasmic domain of HrcU. To test for proteolytic cleavage,
GST-HrcU and GST-HrcU-c-Myc were analyzed by immuno-
blotting of E. coli protein extracts, using GST- and c-Myc-specific
antibodies. Both proteins and several degradation products were
Control of HrpB2 Secretion
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GST-HrcU-c-Myc and a smaller protein of approximately 20 kDa
were also detected by a c-Myc specific antibody. The smaller
protein presumably corresponds to the C-terminal cleavage
product of HrcU (see Fig. 4A), indicating that GST-HrcU fusions
are proteolytically cleaved (Fig. 4B).
For protein-protein interaction studies, GST-HrcU and GST-
HrcU255–357 (HrcU C-terminal domain), immobilized on gluta-
thione sepharose, were incubated with HrpB2-c-Myc. HrpB2-c-
Myc eluted with GST-HrcU and GST-HrcU255–357, but not with
GST alone, suggesting that HrpB2 interacts with the C-terminal
domain of HrcU (Fig. 5A and B).
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Figure 2. Secretion of HrpB2 is suppressed by HpaC. (A) Secretion of HrpB2-c-Myc is enhanced in hpaC deletion mutant strains. Strains 85* (wt)
and 85*DhpaC (DhpaC) both synthesizing HrpB2-c-Myc were incubated in secretion medium. Total cell extracts (TE) and culture supernatants (SN)
were analyzed by immunoblotting, using antibodies specific for the c-Myc epitope and HrpF, respectively. The blot was overexposed to visualize
HrpB2-c-Myc in the culture supernatant of strain 85*. As expected, secretion of HrpF was reduced in the hpaC deletion mutant [31]. (B) The native
HrpB2 protein is strongly secreted by strain 85*DhpaC. In vitro secretion assay with X. campestris pv. vesicatoria strains 85* (wt), 85*DhpaC (DhpaC)
and 85*DhpaC expressing hpaC-c-myc from plasmid pDMhpaC as indicated. TE and SN were analyzed by immunoblotting, using HrpB2- and c-Myc-
specific antibodies. (C) Secretion of HrpB2 is dependent on the T3S system. Strains 85* (wt), 85*DhrpB2 (DhrpB2), 85*DhpaC (DhpaC) and
85*DhpaCDhrpE (DhpaCDhrpE) were incubated in secretion medium. TE and SN were analyzed by SDS-PAGE and immunoblotting, using HrpB2- and
HrpF-specific antibodies. (D) The T3S signal of HrpB2 is located between amino acids 10 and 25. Strains 85* (wt) and 85*DhpaC (D) carrying
expression constructs encoding HrpB2-c-Myc and HrpB2D10–25-c-Myc as indicated were incubated in secretion medium. TE and SN were analyzed by
SDS-PAGE and immunoblotting, using c-Myc epitope- and HrpF-specific antibodies, respectively.
doi:10.1371/journal.ppat.1000094.g002
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separated on a 2% agarose gel and stained with ethidium bromide. For a negative control (-), the template was replaced by water. (B) GST pull-down
assays with HpaC and HrpB2 derivatives. GST and GST-HpaC were immobilized on glutathione sepharose and incubated with an E. coli lysate
containing HrpB2-c-Myc and HrpB226–130-c-Myc, respectively. The total cell lysate (TE) of E. coli expressing HrpB2-c-Myc and HrpB226–130-c-Myc,
respectively, and eluted proteins (eluate) were analyzed by SDS-PAGE and immunoblotting, using antibodies directed against the c-Myc epitope and
GST, respectively. GST and GST fusion proteins are marked by asterisks, lower bands are degradation products. (C) The global T3S chaperone HpaB
does not interact with HrpB2. GST and GST-HpaB were immobilized on glutathione sepharose and incubated with HrpB2-c-Myc. TE and eluate were
analyzed as described in (B).
doi:10.1371/journal.ppat.1000094.g003
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not with the full-length protein
HrcU homologs from animal pathogenic bacteria are involved in
the T3S substrate specificity switch [37,39]. We therefore tested a
possible interaction between HrcU and HpaC, which presumably
acts as a T3S4 protein (see also below). When GST-HrcU was
immobilized on glutathione sepharose and incubated with HpaC-c-
Myc, we did not detect HpaC-c-Myc in the eluate (Fig. 5C). By
contrast, HpaC-c-Myc coeluted with GST-HrcU255–357, suggesting
thatitinteractswiththeC-terminaldomainofHrcUbutnotwiththe
full-length protein (Fig. 5D). Since GST-HrcU is proteolytically
cleaved (see Fig. 4B), we assume that the protein is correctly folded.
Our data therefore suggest that the interaction between HpaC and
HrcU depends on a certain conformation of the HrcU C terminus
that is altered in the context of the full-length protein.
The C-terminal domain of HrcU does not interact with
HrpE, XopA and XopF1
Next, we investigated whether the C-terminal domain of HrcU
also interacts with other secreted proteins, e.g., the putative
translocon protein XopA, the pilus protein HrpE and the effector
protein XopF1. For this, GST, GST-HpaC, GST-XopA and GST-
HrpE were immobilized on glutathione sepharose and incubated
with HrcU-c-Myc. Fig. 6A shows that the C-terminal cleavage
product of HrcU (see above) was detected in the eluate of GST-
HpaC but not of GST-XopA or GST-HrpE. This suggests that the
C-terminal domainof HrcU interacts with HpaC but not with HrpE
and XopA. We did not detect full-length HrcU-c-Myc in the eluate
of GST-HpaC (Fig. 6A), which confirms our previous observation
that HpaC specifically interacts with the C-terminal domain of
HrcU but not with the full-length protein (see Fig. 5C and D).
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lower bands are degradation products. (B) HrpB2 binds to the C-terminal domain of HrcU. GST and GST-HrcU255–357 were immobilized on glutathione
sepharose and incubated with HrpB2-c-Myc. TE and eluate were analyzed as described in (A). (C) Interaction studies with HpaC and HrcU. GST and
GST-HrcU were immobilized on glutathione sepharose and incubated with an E. coli lysate containing HpaC-c-Myc. TE and eluate were analyzed as
described in (A). (D) HpaC binds to the C-terminus of HrcU. GST and GST-HrcU255–357 were immobilized on glutathione sepharose and incubated with
HpaC-c-Myc. TE and eluate were analyzed as described in (A).
doi:10.1371/journal.ppat.1000094.g005
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effector protein XopF1, we expressed XopF1 as a C-terminally c-
Mycepitope-taggedderivative becausea GST-XopF1 fusionprotein
was unstable in E. coli. XopF1-c-Myc was incubated with GST-
HrcU, GST-HrcU255–357 and GST-HpaB, which was used as a
positive control for the interaction assay. GST-HpaB was previously
shown to interact with XopF1 [31]. As expected, XopF1-c-Myc was
detected in the eluate of GST-HpaB but did not coelute with GST-
HrcU and GST-HrcU255–357 (Fig. 6B). Taken together, our results
suggest that the C-terminal domain of HrcU does not interact with
the T3S substrates XopA, HrpE and XopF1. This is in contrast to
the C-terminal region of the flagellar HrcU homolog FlhB, which
interacts with several secreted proteins and is therefore presumably
involved in substrate recognition [38].
HpaC contains a putative T3S4 domain that is crucial for
the interaction with the C-terminal domain of HrcU
The finding that HpaC is involved in control of T3S substrate
specificity and interacts with the C-terminal domain of HrcU
suggests that it acts similarly to T3S4 proteins that were identified
in translocation-associated and flagellar T3S systems from animal
pathogenic bacteria. Despite limited sequence conservation,
known T3S4 proteins harbour a structurally conserved T3S4
domain in the C terminus, which is responsible for the substrate
specificity switch [15,45]. PSI-BLAST searches and hydrophobic
cluster analysis showed that the T3S4 domain is not only present
in proteins from animal pathogenic bacteria but also shares weak
sequence similarity with the C terminus of HpaP from Ralstonia
solanacearum [15]. HpaP is 27% sequence-identical to HpaC. A
pairwise sequence alignment of HpaP and HpaC revealed that
most conserved amino acids in the predicted T3S4 domain of
HpaP are also present in HpaC or are substituted by amino acids
with similar chemical properties (Fig. S1).
To investigate whether the predicted T3S4 domain of HpaC
participates in the interaction with the C terminus of HrcU, we
performed GST pull-down assays with C-terminal HpaC deletion
derivatives, which are shown in Fig. 7A. HpaC1–182-c-Myc, which is
deleted in the C-terminal 30 amino acids and thus lacks part of the
predicted T3S4 domain, coeluted with GST-HrcU255–357, but not
with GST alone (Fig. 7B). However, when compared to the full-
length HpaC protein, which has a strong affinity for HrcU255–357,
the interaction between HpaC1–182-c-Myc and GST-HrcU255–357
was significantly reduced (Fig. 7B). By contrast, binding of HpaC1–
182-c-Myc to other known HpaC interaction partners such as HpaB,
XopF1, XopA, HrcV and also the HpaC self-interaction was not
affected (Fig. 7B and C) [31]. Next, we analyzed a HpaC deletion
derivative, HpaC1–118-c-Myc, which lacks the C-terminal 94 amino
acids and thusthecompleteT3S4domain. Thefactthat HpaC1–118-
c-Myc was not detectable in the eluate of GST-HrcU255–357 suggests
that the predicted T3S4 domain of HpaC is important for the
interaction with the C terminus of HrcU (Fig. 7D).
The predicted T3S4 domain of HpaC is crucial for protein
function
To address whether the predicted T3S4 domain of HpaC is also
important for protein function, we expressed HpaC and deletion
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Figure 6. The C-terminal domain of HrcU does not interact with translocon and effector proteins. (A) GST, GST-HpaC, GST-XopA and
GST-HrpE were immobilized on glutathione sepharose and incubated with HrcU-c-Myc. Total cell extract (TE) of E. coli synthesizing HrcU-c-Myc and
eluates were analyzed by immunoblotting, using antibodies directed against the c-Myc epitope and GST, respectively. GST and GST fusion proteins
are marked by asterisks, lower bands are degradation products. (B) GST, GST-HrcU, GST-HrcU255–357 and GST-HpaB were immobilized on glutathione
sepharose and incubated with XopF1-c-Myc. TE and eluate were analyzed as described in (A).
doi:10.1371/journal.ppat.1000094.g006
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HpaC1–118-c-Myc and HpaC1–182-c-Myc failed to complement the
hpaC mutant phenotype with respect to (i) disease symptom
formation and the HR induction in the plant, and (ii) oversecretion
of HrpB2 in vitro (Fig. 8A and B). Furthermore, HpaC1–118-c-Myc
and HpaC1–182-c-Myc did not restore the deficiency in HrpF
secretion in strain 85*DhpaC (Fig. 8B). We therefore speculate that
the T3S4 domain of HpaC and thus the interaction with the C-
terminal domain of HrcU is essential for the HpaC-dependent
substrate specificity switch.
Discussion
In this study, we analyzed the pathogenicity factors HrpB2 and
HpaC from X. campestris pv. vesicatoria. We discovered that HrpB2 is
not only crucial for secretion of effectors but also of extracellular
components of the secretion apparatus, i.e., the putative translocon
proteins XopA and HrpF and the pilus protein HrpE. Since HrpB2
is itself secreted by the T3S system, it is presumably one of the first
substrates that travels the secretion apparatus [25]. The analysis of
N-terminal HrpB2 deletion derivatives revealed that the secretion
signal of HrpB2 is located between amino acids 10 to 25 and is
crucial for protein function. It is therefore possible that HrpB2 is an
extracellular component of the secretion apparatus that promotes
pilus assembly. However, HrpB2 is probably not a major pilus
subunit since only low amounts of HrpB2 are secreted by the T3S
system. Notably, the pilus protein HrpE is required for HrpB2
secretion and vice versa, suggesting that HrpB2 is not part of an
extracellular needle-like structure below the pilus. An analogous
finding was recently reported for the symbiotic bacterium Rhizobium
strain NGR234. Pilus assembly and T3S in strain NGR234 depends
onthesecretedproteinNopBthatpresumablyassociateswithNopA,
which is the major pilus subunit [46,47].
The second important finding is that secretion of HrpB2 from X.
campestris pv. vesicatoria is suppressed by the export control protein
HpaC, which promotes secretion of translocon and effector proteins
[31]. Proteins that differentially regulate secretion of different T3S
substrates were described for flagellar or translocation-associated
T3S systems andinclude,e.g.,theflagellar chaperoneFliSandT3S4
proteins from animal pathogenic bacteria [12–14,48,49]. We
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immobilized on glutathione sepharose and incubated with HpaC-c-Myc and HpaC1–182-c-Myc as indicated. Total cell extracts (TE) of E. coli
synthesizing HpaC-c-Myc and HpaC1–182-c-Myc, respectively, and eluates were analyzed by immunoblotting, using antibodies directed against the c-
Myc epitope and GST, respectively. GST fusion proteins are marked by asterisks, lower bands are degradation products. (C) HpaC1–182-c-Myc interacts
with known HpaC interaction partners. GST and GST fusion proteins containing XopF1, XopA, HrcV, HpaC and HpaB as indicated on the right side of
the blots were immobilized on glutathione sepharose and incubated with HpaC1–182-c-Myc. TE and eluate were analyzed by immunoblotting, using a
c-Myc-specific antibody. (D) The C terminal 94 amino acids of HpaC are crucial for the interaction with the C-terminal domain of HrcU. GST and GST-
HrcU255–357 were bound to glutathione sepharose and incubated with HpaC-c-Myc and HpaC1–118-c-Myc, respectively. TE and eluate were analyzed as
described in (B).
doi:10.1371/journal.ppat.1000094.g007
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specificity of the secretion apparatus from early (HrpB2) to later
(transloconandeffectorproteins)T3Ssubstrates.Webelievethatthis
substrate specificity switch takes place at the protein level because
HpaC interacts with HrpB2 and with the C-terminal domain of
HrcU, which belongs to the FlhB/YscU family of inner membrane
proteins [3,12,13]. This is in agreement with our previous finding
that HpaC binds to different T3S substrates including translocon
and effector proteins and also interacts with conserved inner
membrane components of the T3S system such as HrcV [31]. It
was therefore proposed that HpaC acts as a linker between secreted
proteins and the secretion apparatus [31]. However, HpaC is
dispensable for secretion of HrpB2. Targeting of HrpB2 to the
secretion apparatus is presumably mediated by the C-terminal
domain of HrcU, which interacts with both HrpB2 and HpaC. The
latter interaction presumably depends on a certain conformation of
the HrcU C terminus since we did not detect binding of HpaC to
full-length HrcU.
The analysis of HpaC deletion derivatives revealed that the
HrcU-binding site is located in the C terminus of HpaC, which
contains the putative T3S4 domain [15] and is required for
protein function. This observation suggests that the interaction
between HpaC and the C-terminal domain of HrcU is required
for HpaC-mediated suppression of HrpB2 secretion. Our data are
reminiscent of the finding that the T3S4 protein FliK from
Salmonella spp. interacts with the C-terminal domain of the HrcU
homolog FlhB [37,38]. It was proposed that binding of FliK
induces a conformational change in the C–terminal cytoplasmic
domain of FlhB and thus alters the substrate specificity of the
flagellar T3S system from secretion of hook components to
filament proteins [12,50]. Since the C-terminal domain of FlhB
interacts with several secreted proteins, it presumably serves as a
docking point for T3S substrates [37,38]. This clearly differs from
the FlhB homolog HrcU from X. campestris pv. vesicatoria since the
C-terminal domain of HrcU does not interact with translocon and
effector proteins that were tested in this study. It is conceivable
that T3S substrate binding in X. campestris pv. vesicatoria is mediated
by other conserved inner membrane components of the T3S
system such as HrcV or the putative ATPase HrcN [3].
The precise mechanism underlying the HpaC/HrcU-mediated
substrate specificity switch in X. campestris pv. vesicatoria remains to
be determined. We speculate that after activation of the T3S
system, binding of HpaC to the C-terminal domain of HrcU
inhibits the interaction between this domain and HrpB2 and thus
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Figure 8. The C-terminal T3S4 domain of HpaC is crucial for protein function. (A) Complementation studies with HpaC derivatives. Strains
85-10 and 85-10DhpaC carrying the empty vector (-) or expression constructs encoding HpaC-c-Myc, HpaC1–118-c-Myc and HpaC1–182-c-Myc as
indicated were inoculated into leaves of susceptible ECW and resistant ECW-10R pepper plants. For the better visualization of the HR, which was
observed for strains 85-10 and 85-10DhpaC expressing hpaC-c-myc, leaves were bleached in ethanol two days after inoculation. Dashed lines indicate
the infiltrated areas. (B) The C-terminal T3S4 domain of HpaC is crucial for T3S. X. campestris pv. vesicatoria strains 85* and 85*DhpaC carrying empty
vector (-) or expression constructs encoding C-terminally c-Myc epitope-tagged derivatives of HpaC, HpaC1–118 and HpaC1–182 as indicated were
incubated in secretion medium. Total cell extracts (TE) and culture supernatants (SN) were analyzed by SDS-PAGE and immunoblotting, using
antibodies directed against HrpB2, HrpF and the c-Myc epitope, respectively.
doi:10.1371/journal.ppat.1000094.g008
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revealed that HrpB2-c-Myc coelutes with GST-HrcU255–357
irrespective of the presence of HpaC, suggesting that all three
proteins can form a complex. It still remains to be investigated
whether both proteins simultaneously bind to the C-terminal
domain of HrcU or whether they are both present in the eluate
because they interact with each other.
Taken together, our data suggest that plant and animal
pathogenic bacteria share similar mechanisms to switch the
substrate specificity of the T3S system but that they differ in the
components that recognize T3S substrates. Another important
difference between plant and animal pathogenic bacteria concerns
the length control of extracellular structures associated with the
membrane-spanning secretion apparatus. In translocation-associ-
ated and flagellar T3S systems from animal pathogenic bacteria,
the substrate specificity switch is coupled to length control of
needle and hook structures. In the flagellar T3S system from
Salmonella spp., for instance, FliK activates secretion of filament
proteins after hook formation. Deletion of fliK leads to elongated
hook structures, suggesting that FliK is required for hook length
control [51–53]. Similarly to FliK, the T3S4 protein YscP from
Yersinia spp. determines needle length in the translocation-
associated T3S system [12]. Since YscP is itself secreted it was
proposed that the N terminus of YscP anchors to the tip of the
growing needle while the C terminus of the protein remains
attached to the secretion apparatus and activates the substrate
specificity switch [54]. According to this model, T3S4 proteins act
as molecular rulers that are coupled to a substrate specificity switch
[12,15]. The molecular ruler model was challenged by the finding
that the T3S4 protein InvJ from Salmonella typhimurium is required
for formation of the inner rod of the T3S apparatus. It was
suggested that formation of the inner rod triggers a conformational
change in the secretion apparatus that leads to the substrate
specificity switch [55]. This model is supported by the recent
finding that the T3S4 protein YscP from Yersinia controls secretion
of the predicted inner rod protein YscI [56]. Wood et al. identified
YscI point mutants that allow effector secretion in the absence of a
detectable needle structure, suggesting that the needle is not
required for the substrate specificity switch.
The future challenge is to investigate the molecular mechanisms
underlying the HpaC-mediated T3S substrate specificity switch in
X. campestris pv. vesicatoria. Since HpaC is not secreted by the T3S
system, it presumably does not act as a molecular ruler protein
[31]. Electron microscopy studies have suggested that pilus length
is not controlled by HpaC [26]. Furthermore, it should be
emphasized that secretion of the Hrp pilus subunit HrpE is not
affected in hpaC mutants [31]. In contrast to the relatively short
(approximately 50 nm) T3S needle from animal pathogenic
bacteria, the Hrp pilus from plant pathogens can reach a length
of up to 2 mm that cannot be bridged by a single proteinaceous
molecular ruler. We therefore speculate that HpaC acts as a T3S4
protein that is not involved in length control of extracellular
structures of the T3S system. This hypothesis is supported by the
fact that secretion-deficient derivatives of the T3S4 proteins YscP
and FliK are still active, indicating that length control and
substrate specificity switch functions can be uncoupled [54,57].
Materials and Methods
Bacterial strains and growth conditions
Bacterial strains and plasmids used in this study are listed in
Table 1. E. coli cells were cultivated at 37uC in lysogeny broth (LB).
X. campestris pv. vesicatoria strains were grown at 30uC in NYG
medium [58] or in minimal medium A [59] supplemented with
sucrose (10 mM) and casamino acids (0.3%). Plasmids were
introduced into E. coli by electroporation and into X. campestris pv.
vesicatoria by conjugation, using pRK2013 as a helper plasmid in
triparental matings [60]. For the generation of strain
85*DhpaCDhrpE, pOK-hrpED9-93, which is a derivative of the
suicide plasmid pOK1 (see Table 1), was introduced into the
genome of X. campestris pv. vesicatoria strain 85*DhpaC by
conjugation. Double cross-overs resulted in deletion mutants that
were selected as described [28].
Antibiotics were added to the media at the following final
concentrations: ampicillin, 100 mg/ml; kanamycin, 25 mg/ml;
rifampicin, 100 mg/ml; spectinomycin, 100 mg/ml; tetracycline,
10 mg/ml.
Plant material and plant inoculations
The near-isogenic pepper cultivars Early Cal Wonder (ECW),
ECW-10R and ECW-30R [61] were grown and inoculated with X.
campestris pv. vesicatoria as described previously [22]. Bacteria were
hand-infiltrated into the intercellular spaces of leaves at concentra-
tions of 2610
8 cfu/ml in 1 mM MgCl2 if not stated otherwise. The
appearance of disease symptoms and the HR were scored over a
period of three to five days after inoculation. For better visualization
of the HR, leaves were bleached in 70% ethanol.
RNA analyses
For RT-PCR analysis, bacteria were grown in secretion
medium. RNA extraction and cDNA synthesis were performed
as described [62] and hrpB2 transcripts were amplified by PCR. To
exclude that RNA preparations contained genomic DNA, total
RNA was used as a template in a control PCR using hrpB2-specific
primers. The lack of detectable hrpB2 amounts suggested that the
RNA preparations were DNA-free (data not shown). Sequences of
primers used in this study are available upon request.
Generation of hrpB2 expression constructs
For the generation of hrpB2 expression constructs, hrpB2 and N-
terminal deletion derivatives were amplified by PCR from X.
campestris pv. vesicatoria strain 85-10 and cloned into the EcoRI and
HindIII sites of pDSK602. To create c-Myc epitope-tagged
derivatives of HrpB2, hrpB2 and truncated gene fragments were
subcloned into the EcoRI/SacI sites of pC3003, in frame with a
triple-c-myc epitope-encoding sequence, and the resulting inserts
were introduced into the EcoRI/HindIII sites of pDSK602. For the
generation of expression constructs encoding HrpB2D10–25 and
HrpB2D10–25-c-Myc, full-length hrpB2 cloned into pUC119 or
pC3003 was used as template for a PCR. PCR products were
religated and the respective inserts were cloned into pDSK602.
Generation of hrcU expression constructs
For the generation of GST fusion proteins, full-length hrcU and a
fragment encoding amino acids 255 to 357, respectively, were
amplified by PCR and cloned into the EcoRI/XhoI sites of pGEX-
2TKM, respectively, downstream and in frame with the GST-
encoding sequence. To construct a C-terminally c-Myc epitope-
tagged HrcU derivative, hrcU was amplified by PCR, inserted into
pENTR/D-TOPO and recombined into pDGW4M using Gateway
technology (Invitrogen, Carlsbad, Calif.). pDGW4M is a Gateway-
compatible derivative of pDSK602 containing attR sites, chloram-
phenicol resistance and ccdB genes and the 46 c-Myc-encoding
sequence of vector pGWB16 inserted into the EcoRI/HindIII sites.
To generate a GST-HrcU-c-Myc expression construct, hrcU was
amplified by PCR, subcloned by SacI and partial EcoRI digest in
pC3003, which contains a triple c-myc-encoding sequence and
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a gst-encoding sequence.
Secretion experiments and protein analysis
In vitro secretion assays were performed as described [27]. Total
cell extracts and culture supernatants were analyzed by SDS-
PAGE and immunoblotting. We used polyclonal antibodies
specific for HrpF [27], XopA [29], AvrBs3 [63] and HrpB2
[25], respectively, and monoclonal anti-c-Myc and anti-GST
antibodies (Amersham Pharmacia Biotech, Freiburg, Germany).
Horseradish peroxidase-labelled anti-rabbit, anti-mouse and anti-
goat antibodies (Amersham Pharmacia Biotech) were used as
secondary antibodies. Antibody reactions were visualized by
enhanced chemiluminescence (Amersham Pharmacia Biotech).
To ensure that no bacterial lysis had occurred, blots were routinely
reacted with an antibody specific for the intracellular protein
HrcN (data not shown) [25].
GST pull-down assays
GST pull-down assays were performed as described previously
[31]. Briefly, GST and GST fusion proteins were expressed in E.
coli and bacterial cells from 50 ml cultures were broken with a
French press. GST and GST fusions were immobilized on
glutathione sepharose and incubated with a c-Myc epitope-tagged
derivative of the putative interaction partner. Bound proteins were
eluted with 10 mM reduced glutathione. 5 ml total protein lysates
Table 1. Bacterial strains and plasmids used in this study.
Relevant characteristics
a Reference or source
X. campestris pv. vesicatoria
85-10 pepper-race 2; wild type; Rif
r [64]
85* 85-10 derivative containing the hrpG* mutation, which renders hrp gene
expression constitutive
[34]
85*DhrpB2 nonpolar hrpB2 deletion mutant of strain 85* [25]
85*DhpaC nonpolar hpaC deletion mutant of strain 85* [31]
85-10DhpaC nonpolar hpaC deletion mutant of strain 85-10 [31]
85*DhpaB nonpolar hpaB deletion mutant of strain 85* [30]
85*DhpaBDhpaC hpaB/hpaC double mutant of strain 85* [31]
85*DhpaCDhrpF hpaC/hrpF double mutant of strain 85* this study
85*DhpaCDhrpE hpaC/hrpE double mutant of strain 85* this study
85E*DhrcU hrcU deletion mutant of strain 85E* [26]
E. coli
DH5a F
2 recA hsdR17(rk
2,mk
+) W80dlacZ DM15 Bethesda Research Laboratories, Bethesda, Md.
DH5al pir F
2 recA hsdR17(rk
2,mk
+) W80dlacZ DM15 [lpir] [65]
Plasmids
pBlueskript(II) KS phagemid, pUC derivative; Ap
r Stratagene
pUC119 ColE1 replicon; Ap
r [66]
pC3003 pUC19 containing a triple c-myc tag; Ap
r J. Ka ¨mper
pENTR/D TOPO Gateway system donor vector; Km
r Invitrogen
pDSK602 broad-host-range vector; contains triple lacUV5 promoter; Sp
r [67]
pGWB16 binary expression vector, contains attR1-CmR-ccdB-attR2 upstream
of 46c-myc epitope-encoding sequence
[68]
pGEX-2TKM GST expression vector; ptac GST lacI
q pBR322 Stratagene
ori;A p
r, derivative of pGEX-2TK with polylinker of pDSK604 [69]
pGEX-6P-1 GST expression vector Stratagene
pOK1 suicide vector; sacB sacQ mobRK2 oriR6K; Sm
r [28]
pOK-hrpED9-93 pOK1 derivative containing hrpE with a stop codon insertion after codon 8 [26]
pRK2013 ColE1 replicon, TraRK
+ Mob
+;K m
r [60]
pL6HrpE50AvrBs3D2 pLAFR6 derivative encoding HrpE1–50-AvrBS3D2 under control of the hrpE
promoter
[36]
pDMhpaB pDSK604 derivative encoding HpaB-c-Myc [30]
pDMhpaC pDSK604 derivative encoding HpaC-c-Myc [31]
pGhpaB pGEX-2TKM expressing GST-HpaB [31]
pGhpaC pGEX-2TKM expressing GST-HpaC [31]
pGxopA pGEX-2TKM expressin GST-XopA [30]
pGxopF1 pGEX-2TKM expressin GST-XopF1 [31]
aAp, ampicillin; Km, kanamycin; Rif, rifampicin; Sp, spectinomycin; r, resistant.
doi:10.1371/journal.ppat.1000094.t001
Control of HrpB2 Secretion
PLoS Pathogens | www.plospathogens.org 11 June 2008 | Volume 4 | Issue 6 | e1000094and 20 ml eluted proteins were analyzed by SDS-PAGE and
immunoblotting. For the generation of GST-HrpE, hrpE was
amplified by PCR and cloned into the EcoRI/XhoI sites of pGEX-
2TKM. The same blot was always incubated with an anti-c-Myc
and an anti-GST antibody, respectively.
Supporting Information
Figure S1 The C terminus of HpaC contains a predicted T3S4
domain. Sequence alignment of HpaC from X. campestris pv.
vesicatoria strain 85-10 (accession number CAJ22055) and HpaP
from R. solanacearum (accession number CAB58249). Amino acid
sequences were aligned using CLUSTAL W (http://www.ebi.ac.
uk/clustalw/). Conserved amino acids are shaded black, similar
amino acids are shaded grey. The black bar indicates the predicted
T3S4 domain in HpaP, stars refer to amino acids that are
conserved among HpaP and T3S4 domain-containing proteins
[15].
Found at: doi:10.1371/journal.ppat.1000094.s001 (0.56 MB EPS)
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